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Background
Symptom and quality of life (QOL) instruments are often used in clinical trials to reach 
significant conclusions. However, these instruments need to be validated (with respect 
to their measurement properties as construct validity, reliability, reproducibility, discri-
minant ability and/or responsiveness) before they can be used to judge statistical sig-
nificance. Ordinal scores are often assigned. For example, the Quality of Life Instrument 
breast cancer patient version is a 46 item ordinal scale ranging from 0 = worst outcome 
to 10 = best outcome. Asthma quality of life questionnaire (AQLQ) is often scaled from 
1 to 7 with higher score reflects better functions. When baseline scores are available, 
common sense dictates that baseline values should be incorporated in the analysis in 
order to improve efficiency and reduce imbalances. However, it is not immediately clear 
how the baseline values should be used in the statistical analysis. One of the popular 
ways of analyzing the scores from baseline and outcome is to use nonparametric meth-
ods (such as Wilcoxon signed-rank test or Wilcoxon rank-sum test) which uses the rank 
of the raw scores. Since no assumptions about the probability distributions are made, 
such nonparametric methods are meaningful but could have considerably less power. 
The other popular avenue is to analyze the raw scores as change or percent change from 
the baseline. Some references in the medical literature, by no means complete, include 
Pearlman et al. (1992), Juniper et al. (1993), Chervinsky et al. (1994), Israel et al. (1996). 
There are analysis using number of days without symptoms (where daily recordings are 
used for a binary classification: 1 if no/nominal symptom, 0 otherwise) as the observa-
tions; see Pearlman et al. (1992), Dahl et al. (1994). There is a body of literature which 
points out the advantages of using baseline scores as covariates; see Blomqvist (1977), 
Salsburg (1981), Hayes (1988), Kaiser (1989), and Senn (1989) and the references therein. 
Abstract 
We investigate the effect of power transformation of raw scores on the responsiveness 
of quality of life survey. The procedure maximizes the paired t-test value on the power 
transformed data to obtain an optimal power range. The parallel between the Box–Cox 
transformation is also investigated for the quality of life data.
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Symptom or QOL scores are often analyzed using linear models (e.g., ANOVA or 
Cochran–Mantel–Haenszel test using the assigned scores); see Agresti (1990), Canover 
(1980). Stratified analysis based on baseline strata can give information about how the 
responses differ for different baseline values and whether pooling or ignoring baseline 
values makes sense. It is evident from the above discussion that there are many methods 
for analyzing QOL data and no standards are implemented in practice. A major draw-
back of methods that use the raw scores rather than the ranks is that they can depend 
critically on the scale used for the score assignment. For example, a score assignment 
from 0 to 4 may have a difference of 2 between the scores of moderate to maximum 
symptom whereas it is a difference of 3 for a score assignment of 0–6. Thus, the signifi-
cance results will be highly sensitive to the particular scale used for score assignment. 
The results can mislead the reader about the treatment magnitudes and make it nearly 
impossible to compare across studies. The analysis can induce outliers.
Responsiveness—the sensitivity of a measure to a clinically relevant change in health is 
an essential property of outcome measures for intervention studies. The main objective 
of this paper is to study the responsiveness to change of the assignment of the scores in 
the AQLQ measure. We do this under the paradigm of power group of transformation, 
by studying the sensitivity of the methods for validating QOL instruments to the assign-
ment of the scores.
There is no consensus regarding how best to assess the responsiveness to change of 
measures; here we looked at responsiveness as measures of treatment effect. Such meas-
ures tell us little about how well the instrument serves its purpose, which is not our 
objective; but are of customary use in interpreting score changes (Terwee et al. 2003). 
We look at several existing tests and also suggests some new tests and study how the 
results vary as we change the scale of measurements. We want to reiterate that it is not 
our objective to build new methodologies that circumvent the problem of assignment 
of scores (even though we do define alternative methods, but only to bring more clarity 
to our investigation) but rather point out the deficiencies that plague some of the com-
monly used methods and how sensitive they are to the actual scale of measurements. 
In “Within treatment comparison”, we describe the data and the treatments. We also 
investigate the susceptibility of statistical conclusions about within treatment compari-
sons when different methods are used for power transformation. We look at the problem 
from two different objectives, one is to transform the data in order to achieve normal-
ity (which is the underlying assumption of the quantitative analysis) and the other to 
get the most significant test statistic. In “Between treatment comparison”, we perform 
similar analysis regarding the sensitivity of the between treatment comparisons to the 
power transformation. We also use the novel method of generalized confidence interval 
to make the sensitivity analysis under unequal treatment variances. In “Conclusion”, we 
summarize our results and provide some recommendation.
Within treatment comparison
In this section we use a dataset from the ‘Quality of Life’ survey of an undisclosed clini-
cal study to perform our investigation and to illustrate our methodology.
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Quality of life data
There were a total of 689 asthma patients undergoing the trial. Subjects were non-smok-
ers aged 15–70 years with ≥1 year history of asthma symptoms who met the inclusion 
criteria. Patients were excluded if they have other pulmonary disorder, emergency treat-
ment for asthma within 1 month, hospitalization within 2 months or respiratory tract 
infection within 3 weeks. The eligible patients were randomized to each of the four treat-
ments: 2A = M/UC, 2B = M/M, 2C = P/UC and 2D = P/M where M, P and UC stand 
for the active drug (Montelukast), placebo and usual care, respectively and A/B stands 
for application of treatment A followed by treatment B.
For each patient the baseline responses and post treatment responses for the AQLQ 
with 13 items were recorded. The subsequent outcomes after the baseline observations 
were recorded in a series of visits over the entire period of the study. For illustrative pur-
poses we have chosen outcome values only from the first visit (visit = 6) after the base-
line observation (visit = 3). All subjects for whom complete data records were available 
were included in this analysis (632 subjects out of 689). There were 57 subjects excluded 
due to missing the first post dose visit. Among the subjects who had both visits, the 
treatment group sizes were n1 = 146, n2 = 274, n3 = 70 and n4 = 142.
The asthma specific QOL questionnaire can be further classified into two domains, 
one corresponding to activity level and the other corresponding to emotional level. For 
preliminary analysis we have ignored this further grouping. Thus the observations are 
xijkl , i = 1, . . . , 4, j = 1, . . . , ni, k = 1, . . . , 13, l = 0, 1, corresponding to the answer to 
the kth question in the lth period (l = 0 for baseline and l = 1 for post treatment) for the 
jth patient in the group receiving the ith treatment.
Paired comparison
The baseline and outcome values within a patient are correlated and can be thought of 
as matched groups. A suitable test for dependent categorical variables can be used for 
finding out whether there is any difference in the baseline and the outcome distribution 
within treatments. One can also treat the observations as continuous values and per-
form a paired t-test to test for differences between pre and post treatment responses. Of 
course, when the data are truly continuous and normal, the paired t-test has optimality 
property such as most powerful unbiased test. Thus, one recourse could be to first try to 
transform the data to normal by means of transformations, such as the power group of 
transformation proposed by Box–Cox.
Wilcoxon signed rank test
The Wilcoxon signed rank test can be used to test for symmetry around zeros of the dif-
ference between the outcome and baseline within a treatment group; see Agresti (1990). 
In Table 1 we tabulate the normalized test statistic value of the Wilcoxon signed-rank 
test and the corresponding p value obtained from the asymptotic null distribution for 
each treatment group. The observations used the difference between the outcome and 
the baseline of the average of the 13 questionnaire scores for each patient within a treat-
ment group.
Even though all treatment groups give significant results, clearly the two groups associ-
ated with placebo are less significant than the two groups associated with the treatment.
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Box–Cox transformation
In Box–Cox transformation the transformed variables are
where g is the geometric mean of the observations g = (∏ xi)1/n. The data dependent 
constant g−1 comes in as the Jacobian of the power transformation. Then one looks at 
the variance of the transformed observations to choose an optimal value for . Figure 1 
plot the negative of the log variance of the transformed observations as a function of the 
power  in a region  ∈ [−6, 6]. The value of  that minimizes the variance is approxi-
mately max = 1.77 for both treatments 2B and 2C. Now if the paired t-test is performed 
with the transformed data, the absolute values of the t statistic are 4.7 and 14.5 for treat-
ments 2B and 2C, respectively.
Most significant paired t‑statistic
Another way of approaching the problem of testing is maximizing the paired t-test value 
(in absolute terms) over different power transformations. The rational is to transform the 
scoring system to obtain most efficiency in detecting mean differences. This will change 





g−1  = 0
xi −1
g−1  �= 0,
Table 1 Wilcoxon signed-rank test
Treatment group W p value
2A 5.77 <0.00001
2B 5.94 <0.00001
2C 2.40  0.01630
2D 3.51  0.00040
Fig. 1 Box–Cox trans
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for each patient receiving treatment i are dij = 13−1
∑13
k=1(xijk1 − xijk0), j = 1, 2, . . . , ni. 
The paired t-test for the group receiving treatment i is then t = √nid¯/sd where d¯ 
is the mean of the observed dij and sd is the sample standard deviation of the dij. We 
propose to transform the raw scores xi to yi by the transformation (2.1) and compute a 
paired t-test value t() for each value of  and choose our estimator for the exponent as 
max = argmax|t()|. Note that this simply entails transforming the data to xijkl as the 
t function is invariant to transformation of the form axijkl + b. In Fig. 2 we present the 
absolute value of the paired t statistic for the treatment groups receiving treatment 2B 
and 2C. For treatment 2B the maximum of the t value is obtained at  = 1.86 which is 
very close to that obtained through the Box–Cox transformation, but not exactly the 
same. A justification of this approach can be that because the exact type I error is not 
known, the objective of maximizing power can be directly obtained through the class of 
transformation that is often used to get more normal looking data, a case desirable for 
optimality of the paired t-test. The exponent that maximizes the power for treatment 
group corresponding to 2C is 3.5 which is substantially different from the value required 
for achieving normality. However, the t values with or without transformation are all sig-
nificant for both groups. The group (2C) getting the placebo still shows significant dif-
ference from the baseline to the outcome. An explanation may be that the mere fact that 
a person is undergoing a trial has a psychological effect which generates this difference.
The results from the paired t-tests after transformation shows the difference in the 
grading from baseline to outcome for different treatments more markedly than the Wil-
coxon signed-rank tests.
Between treatment comparison
In this section we do pairwise comparison of the treatment effects. First we provide 
results for nonparametric tests for treatment differences. Then we investigate the effect 
of power transformation on parametric procedures for testing treatment differences.
Fig. 2 Paired t-statistic
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Wilcoxon rank‑sum test
The data vectors for each treatment groups are the ni average score differences 
between the baseline and outcome for that group. Because the observation lengths 
are different for different treatment groups, we do Wilcoxon rank-sum test for test-
ing treatment differences. The results for the normalized Wilcoxon rank-sum statistics 
[W − E(W )]/√V (W ), where for comparing treatment A and B the expectation and the 
variance of the statistic are nA(nA + nB)/2 and nAnB(nA + nB)/12, respectively, and the 
corresponding p value obtained from the asymptotic null distribution of the test statistic 
are given in Table 2.
Two sample t‑test
For initial investigation of the effect of the power transformation on between treatment com-
parison, we chose to do pairwise analysis rather than multiple comparison. The test statistic 
for pairwise comparison of treatments i and j is a t-statistic with ni + nj − 2 degrees of free-
dom. We report the corresponding Fni+nj−2 statistic obtained from the analysis of variance.
To correct the effect of the baseline, we looked at the difference of average score over 
the 13 questionnaires from baseline to post-treatment response. There are several issues 
one needs to consider before proceeding with treatment comparison based on the trans-
formed data. Of course the baseline and post-treatment scores and different treatment 
scores may need different power transformation for optimal result. However, for dif-
ferent power transformation the scales will be different making treatment comparison 
infeasible.
To analyze the data in the original scale the observations are divided by the Jacobian of 
the transformation after the transformation (similar to what one would do for Box–Cox 
transformation). Thus the new transformed scores for comparing TrtA and TrtB are








and n = nA + nB, (A,B) ∈ {1, 2, 3, 4}. Final analysis is done on the reduced data (aver-
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Table 2 Wilcoxon rank-sum test W
Treatment pair W p value
2A, 2B 1.35 0.175
2A, 2C −1.95 0.051
2A, 2D −1.84 0.066
2B, 2C −0.93 0.353
2B, 2D −0.74 0.460
2C, 2D −0.27 0.786
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As stated before, treatment comparison can be made based on a simple one-way model 
for yij,
Of course the model will be indexed by the exponent  of the power transformation. 
Figure  3, 4 and 5 show the plot of the F-statistic for testing equality of the treatment 
means as a function of . Generally, the unique mode max lies well right of  = 1 ( = 
1.6, 2.1 and 2.9 for treatment comparisons (2A, 2C), (2B, 2C), and (2B, 2D), respec-
tively). This reflects the general right skewed nature of the data. A power transforma-
tion bigger than one may be desirable as it may be argued that scoring system which 
puts more weight on higher score corresponding to more severe symptoms is indeed 
more apt to detect treatment differences. Although the figures show that higher power 
may be gained by making appropriate power transformation, none of the F-statistic val-
ues are significant for this particular example. This may be due to the naive assump-
tion of equal variances for the treatment groups (in this particular example: Bartlett’s 
K-squared =  2.189, df =  3, p value =  0.5341). Given that the observations have been 
transformed through nonlinear transformations, the assumption of equal variances can 
be rather uncomfortable. The procedure can be made much more efficient by treating 
the variances as unknown and possibly unequal. This in this simple model is analogous 
to the classic Behren–Fisher problem for testing equality of means of two normal popu-
lations with unequal variances.
Unequal variances
Even though there are no optimal procedure for dealing with the Behren–Fisher prob-
lem, a novel and appealing way is to use the recent ideas of generalized confidence inter-
vals. The concept is due to Weerahandi (1993) and the basic idea is as follows. Let X be 
(3.4)yij = µ+ τi + eij , i = A,B, j = 1, . . . , ni.
Fig. 3 2A vs 2C
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a random vector whose distribution depends on δ, a scalar parameter of interest and η
, a nuisance parameter. Furthermore, let x denote the observed value of X, the already 
obtained data on X. Then a generalized pivot statistic g(X; x, θ) is a statistic satisfying the 
following conditions:
1. The distribution of g(X; x, θ) is free from any unknown parameters.
2. The observed value of g(X; x, θ), i.e., g(x; x, θ), is equal to m(θ), the parameter of 
interest.
Fig. 4 2B vs 2C
Fig. 5 2B vs 2D ANOVA F-statistic for mean difference
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Confidence intervals for m(θ) are obtained using the percentiles of g(X; x, θ) and are 
known as generalized confidence intervals. The coverage of such a confidence interval 
conditional on the data is equal to the nominal level but the overall coverage may not 
be exactly equal to the nominal level. In fact, the coverage could depend on unknown 
parameters. However, for the Behren–Fisher problem the coverage is remarkably close 
to the nominal level for a variety of parameter configurations; see Weerahandi (1993), 
Weerahand (1995) for details. In general, the percentiles of a generalized pivot statistic 
will have to be numerically obtained, perhaps by simulation.
In our case, the parametric function of interest when comparing treatment B and C is
where µB,µC , σB, σC are the means and standard deviations of the respective popula-
tions. Because the ANOVA statistics perform optimally for normal distribution, we will 
do the mean comparison with the target that the power transformation is increasing effi-
ciency by bringing the empirical distribution closer to normal distribution. In this con-
text we can construct a generalized pivot for the treatment mean differences pretending 
we have normality for the data. The generalized pivot would be
where x¯A, x¯B, sA, sB are the observed sample means and standard deviations and 
X¯A, X¯B, SA, SB are the corresponding population quantities.
We present the results for three pairwise comparisons, 2A vs 2C, 2B vs 2C and 2B vs 
2D. Figures 6, 7 and 8 shows the 95 % generalized confidence bands for the three pair-
wise comparisons where the confidence limits are plotted as a function of the power 
transformation. For comparing 2A to 2C the confidence intervals do not include zero 
showing significant difference at 5  % level. For comparing treatment 2B and 2C, the 
m(µB,µC , σB, σC) = |µB − µC |,


















Fig. 6 2A vs 2C
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confidence limits do include zero. However, for 85 % confidence bands the confidence 
intervals do not include zero for  ∈ [−1, 2] and the shortest length of the interval in 
obtained for  = 2. For comparing treatments 2B and 2D the intervals contain zero for 
all reasonable levels.
Comparing the results of the nonparametric tests and the parametric procedures for 
unequal variances one sees similarity in the treatment comparisons. However, it seems 
that the parametric tests with power transformation may have more power in detecting 
treatment differences. For example, when comparing the treatment 2B and 2C, the non-
parametric test is not significant even though much more significant than the naive two 
sample t-test. But the generalized confidence procedure returns a p value much smaller 
than the nonparametric test.
Fig. 7 2B vs 2C
Fig. 8 2B vs 2D generalized 95 % confidence interval
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Conclusion
In this article we have investigated responsiveness as measures of treatment effect on 
ordinal scores. We have tried to understand the effect of transforming the ordinal scores 
through a power transformation with the objective of attaining a modified scoring sys-
tem which gives the most significant results as opposed to power transformation with 
the goal of achieving normality. We used the quality of life data as the primary example 
and illustrated our methods based on that data. There are several interesting observa-
tions that can be made from the results. The test statistics as a function of the exponent 
are usually unimodal, though not always convex. The power range giving the most sig-
nificant results need not be equal to that obtained from the Box–Cox procedure. The 
transformed data can pick up differences in means which otherwise are insignificant in 
the original data. There are several issues that need to investigated further. The change of 
scales due to the power transformations and its impact on the analysis need to be care-
fully understood. The effect on the power function of the tests need to studied. Compari-
sons should be drawn with nonparametric tests. The overall findings of our investigation 
indicate that methods of analyzing QOL data that actually use the raw scores or change 
or percentage change from baseline tend to be highly sensitive to the method of score 
assignment. Thus, care must be exercised when using any method that uses change or 
percentage change. A proper sensitivity analysis showing robustness of any particular 
method for analyzing Symptoms or QOL scores to score assignment method must pre-
cede any validation of QOL instruments using the method.
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